
August 2026
AI at Lexi, An engineered virus, Turning a gene down, Experiments by robots, A living pesticide, Where the exits are
Insights shaping Lexi Ventures' view of the future
Live Last read · last published · next check

AI at Lexi, An engineered virus, Turning a gene down, Experiments by robots, A living pesticide, Where the exits are

Speeding CRISPR to kids, Claude Science, Psychedelics go mainstream, Weekly strong deodorant, The early-stage squeeze, Investor matching

Summer reading list, A virus that cures cancer, More validation from pharma, In vivo / ex vivo, Fable 5 fears biotech, Don't take our word for it, More pizza

Craig Venter, Mammoth RNA, Drugs design by the SoC playbook, A gene therapy delivery breakthrough

A sickle cell cure for African babies, TippingPoint Biosciences, SpaceX Bio?

How great VC firms are made, Sequencing under $80, More big deals

Dog and cat DNA, Mixed signals at the FDA, Better judgement with AI

The NIH spigot remains open, The big pizza party, Biology's Linux, Deregulation in Europe?

Pizza at JPM, The Blotnick list, Gene therapy gets personal, De-identified data, ApoA-I Milano

Watson lost, Chan-Zuckerberg and rivals, Four billion for Billion, 12 billion for rare diseases, Pfizer wins a peptide, KFSHRC joins Kopra